Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06277609 · ClinicalTrials.gov registry record · Phase 1
A Trial Investigating Lu AF28996 in Healthy Adult Participants
A Phase 1 study, sponsored by H. Lundbeck A/S.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT06277609 is a Phase 1 study that has completed, run by H. Lundbeck A/S. The registered enrollment target is 22 participants.
The verdict
NCT06277609, a Phase 1 study, has completed, sponsored by H. Lundbeck A/S.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate repeated doses of Lu AF28996 in healthy participants and co-administered with two other compounds, and in a separate cohort following co-administration with antibiotics, to see how well the doses are tolerated and what the body does to the drug after administering it.
Interventions
- DRUG Lu AF28996
- DRUG Acetylsalicylic Acid
- DRUG Mefenamic Acid
- DRUG Amoxicillin/clavulanic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2024-02-27 |
| Est. Completion | 2024-05-19 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06277609
The ClinicalTrials.gov registry entry for NCT06277609 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lundbeck A/S, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Lu AF28996 is the first listed.
NCT06277609 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06277609 about?
NCT06277609 is a clinical study titled "A Trial Investigating Lu AF28996 in Healthy Adult Participants". The purpose of this study is to investigate repeated doses of Lu AF28996 in healthy participants and co-administered with two other compounds, and in a separate cohort following co-administration with antibiotics, to see how well the doses are tolerated and what the body does to the drug after admin...
What is the current status of trial NCT06277609?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2024-02-27. Estimated completion is 2024-05-19.
What interventions are being tested in trial NCT06277609?
The interventions under investigation include: Lu AF28996 (DRUG), Acetylsalicylic Acid (DRUG), Mefenamic Acid (DRUG), Amoxicillin/clavulanic acid (DRUG).
Who is sponsoring clinical trial NCT06277609?
This trial is sponsored by H. Lundbeck A/S, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.